OSCR

The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis.

Overview

  1. Melbourne School of Psychological Sciences, The University of Melbourne,Redmond Barry Building, Parkville, VIC 3010 Australia
  2. Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital,635 Elizabeth Street, Melbourne, VIC 3000 Australia
  3. Clinical Outcomes Research (CORe) Unit, Department of Medicine (RMH), The University of Melbourne,635 Elizabeth Street, Melbourne, VIC 3000 Australia
  4. Centre of Excellence for Cellular Immunotherapy and Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital,305 Grattan Street, Melbourne, VIC 3000 Australia
  5. School of Psychology, Deakin University,Victoria, Australia
Institutions: The University of Melbourne (Australia); The Royal Melbourne Hospital (Australia); Deakin University (Australia)
Journal: BMC neurology, volume 26, issue 1, article 544
Dates: received 14 April 2026; accepted 15 June 2026; published online 17 June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s12883-026-05085-z · PMID 42310592 · PMCID PMC13520496 · OpenAlex W7165045947
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: structural MRI / diffusion (modality), human (organism), Alzheimer's / dementia (population), multiple sclerosis (population), clinical / translational (subfield)
Methods: Statistics, fMRI & imaging
Keywords: Multiple sclerosis, Cognitive impairment, Structural neuroimaging markers, Screening, Clinical data
MeSH: Brain*, Cognitive Dysfunction*, Multiple Sclerosis*, Neuroimaging*, Adult, Female, Gray Matter, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Retrospective Studies, White Matter (* major topic)
Topic: Multiple Sclerosis Research Studies (Pathology and Forensic Medicine, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 41 references in the paper

Abstract

Background: Cognitive impairment is common in multiple sclerosis (MS), yet comprehensive cognitive assessment is not universally accessible, and patients need to be triaged for referral. Given the links between brain atrophy and cognition, this study investigated whether routinely collected neuroimaging markers could identify MS patients at risk of cognitive impairment.

Methods: Data were retrospectively analysed from adult MS patients assessed in a specialist cognitive neuroimmunology clinic, who had undergone MRI within 12 months prior to cognitive testing. Normalised brain volume (NBV), normalised grey matter volume (NGMV), normalised white matter volume (NWMV), and corpus callosum index (CCI) were measured using the Siemens MorphoBox automated software. GLMs were estimated to investigate group differences in brain volume metrics between cognitively impaired and non-impaired patients. ROC curves were estimated to investigate screening performance for neuroimaging metrics (Youden’s J). Results are expressed as parameter estimates with 95% bootstrapped confidence intervals (CI).

Results: 120 patients were included (35% cognitively impaired). Cognitively impaired patients had lower NBV (b = − 2.06, 95% CI [− 3.35, − 0.81]) and NWMV (b = − 1.65, 95% CI [− 2.60, − 0.77]). NWMV (area under the curve [AUC] = 0.67, 95% CI [0.57, 0.76]) and CCI (AUC = 0.62, 95% CI [0.51, 0.72]) classified impairment, although sensitivity was low (< 0.70). No clear associations or sufficient classification performance were observed for NGMV. Diagnostic performance improved when neuroimaging markers were statistically combined with relevant demographic information.

Conclusion: The present study did not find strong evidence supporting routinely collected neuroimaging as standalone cognitive screening tools. Classification performance improved when combined with demographic factors, but remained below thresholds for clinical utility. These findings highlight a gap between group-level associations reported in the literature and their translation to individual-level clinical application.

Supplementary Information: The online version contains supplementary material available at 10.1186/s12883-026-05085-z.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

De-identified data and complete analysis may be accessed from the following online data depository: 10.17605/OSF.IO/5BNG6.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 13 MeSH terms, 35 references.

Cite

This paper

Jardine, R. E., Kuznetsova, V., D’Aprano, F., Kalinicik, T., Roberts, S., & Malpas, C. B. (2026). The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis. BMC neurology, 26(1), 544. https://doi.org/10.1186/s12883-026-05085-z

BibTeX

@article{jardine2026use,
author = {Jardine, Reine E. and Kuznetsova, Valeriya and D’Aprano, Fiore and Kalinicik, Tomas and Roberts, Stefanie and Malpas, Charles B.},
title = {{The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis}},
journal = {BMC neurology},
year = {2026},
month = jun,
volume = {26},
number = {1},
pages = {544},
publisher = {BMC},
issn = {1471-2377},
doi = {10.1186/s12883-026-05085-z},
url = {https://doi.org/10.1186/s12883-026-05085-z},
pmid = {42310592},
pmcid = {PMC13520496}
}

RIS

TY - JOUR
AU - Jardine, Reine E.
AU - Kuznetsova, Valeriya
AU - D’Aprano, Fiore
AU - Kalinicik, Tomas
AU - Roberts, Stefanie
AU - Malpas, Charles B.
TI - The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis
T2 - BMC neurology
J2 - BMC Neurol
PY - 2026
DA - 2026/06/17
VL - 26
IS - 1
SP - 544
SN - 1471-2377
PB - BMC
DO - 10.1186/s12883-026-05085-z
UR - https://doi.org/10.1186/s12883-026-05085-z
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s12883-026-05085-z",
"type": "article-journal",
"title": "The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis",
"container-title": "BMC neurology",
"author": [
{
"family": "Jardine",
"given": "Reine E."
},
{
"family": "Kuznetsova",
"given": "Valeriya"
},
{
"family": "D’Aprano",
"given": "Fiore"
},
{
"family": "Kalinicik",
"given": "Tomas"
},
{
"family": "Roberts",
"given": "Stefanie"
},
{
"family": "Malpas",
"given": "Charles B."
}
],
"container-title-short": "BMC Neurol",
"volume": "26",
"issue": "1",
"page": "544",
"DOI": "10.1186/s12883-026-05085-z",
"PMID": "42310592",
"PMCID": "PMC13520496",
"ISSN": "1471-2377",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s12883-026-05085-z",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
17
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/braincomms/fcag162 [code]
Disability profiles in progressive multiple sclerosis reflect pathology distribution, independent of clinical phenotype.
Journal: Brain communications
In common: multiple sclerosis, structural MRI / diffusion, clinical / translational, 3 references
[2] doi:10.1093/braincomms/fcag193 [code]
Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis.
Journal: Brain communications
In common: structural MRI / diffusion, clinical / translational, author Tomas Kalinicik
[3] doi:10.1017/neu.2026.10078 [code]
Improved dietary control results in improvements in indices of white matter structure in adults with phenylketonuria: the ReDAPT study.
Journal: Acta neuropsychiatrica
In common: structural MRI / diffusion, clinical / translational, author Charles B. Malpas
[4] doi:10.1177/20552173261448282 [code]
The constrained brain in multiple sclerosis: Cognitive impairment is related to network-specific coupling of structural and functional connectivity.
Journal: Multiple sclerosis journal - experimental, translational and clinical
In common: multiple sclerosis, structural MRI / diffusion, 3 references
[5] doi:10.1162/netn.a.545 [code]
Structure-function multilayer network integration and cognition in multiple sclerosis.
Journal: Network neuroscience (Cambridge, Mass.)
In common: multiple sclerosis, structural MRI / diffusion, 3 references
[6] doi:10.1002/acn3.70418
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS.
Journal: Annals of clinical and translational neurology
In common: multiple sclerosis, structural MRI / diffusion, clinical / translational, 2 references
[7] doi:10.1093/braincomms/fcag140 [code]
Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing-remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb.
Journal: Brain communications
In common: multiple sclerosis, structural MRI / diffusion, clinical / translational, 2 references
[8] doi:10.3389/fdgth.2026.1691088 [code]
Real-world federated learning for brain imaging scientists.
Journal: Frontiers in digital health
In common: multiple sclerosis, structural MRI / diffusion, 2 references
[9] doi:10.1093/braincomms/fcag134 [code]
Neurophysiological, imaging and neurobiological markers of central fatigue in multiple sclerosis.
Journal: Brain communications
In common: multiple sclerosis, structural MRI / diffusion, 2 references
[10] doi:10.1093/braincomms/fcag043 [code]
Linking movement-related beta oscillations to cortical excitability, structural damage, and fatigue in multiple sclerosis.
Journal: Brain communications
In common: multiple sclerosis, structural MRI / diffusion, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.